These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11019471)

  • 1. Plasma HIV-1 RNA quantitation in HIV infected adult Zimbabweans.
    Chaka WS; Sibanda EN
    Cent Afr J Med; 1999 Sep; 45(9):231-4. PubMed ID: 11019471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
    Mellors JW; Muñoz A; Giorgi JV; Margolick JB; Tassoni CJ; Gupta P; Kingsley LA; Todd JA; Saah AJ; Detels R; Phair JP; Rinaldo CR
    Ann Intern Med; 1997 Jun; 126(12):946-54. PubMed ID: 9182471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
    Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
    AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l.
    García F; Vidal C; Gatell JM; Miró JM; Soriano A; Pumarola T
    AIDS; 1997 Jan; 11(1):53-7. PubMed ID: 9110075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.
    Phillips AN; Eron JJ; Bartlett JA; Rubin M; Johnson J; Price S; Self P; Hill AM
    AIDS; 1996 Jul; 10(8):859-65. PubMed ID: 8828743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse transcriptase activity for quantitation of HIV-1 subtype C in plasma: relation to RNA copy number and CD4 T-cell count.
    Seyoum E; Wolday D; Girma M; Malmsten A; Meselle T; Gronowitz JS; Britton S
    J Med Virol; 2006 Feb; 78(2):161-8. PubMed ID: 16372295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.
    MacArthur RD; Perez G; Walmsley S; Baxter JD; Mullin CM; Neaton JD; ;
    HIV Clin Trials; 2005; 6(3):127-35. PubMed ID: 16192247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
    Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC
    Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for lower CD4+ T cell and higher viral load in asymptomatic HIV-1 infected individuals of India: implications for therapy initiation.
    Kannangai R; Kandathil AJ; Ebenezer DL; Nithyanandam G; Samuel P; Abraham OC; Sudarsanam TD; Pulimood SA; Sridharan G
    Indian J Med Microbiol; 2008; 26(3):217-21. PubMed ID: 18695317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
    Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
    Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 x 10(6) cells/l.
    Chapman LE; Green TA; Ahmed F; Parekh BS; Rimland D; Kaplan JE; Thompson MA; Folks TM
    AIDS; 2000 Jun; 14(9):1135-46. PubMed ID: 10894277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
    Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
    HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study.
    Yerly S; Perneger TV; Hirschel B; Dubuis O; Matter L; Malinverni R; Furrer H; Perrin L
    Arch Intern Med; 1998 Feb; 158(3):247-52. PubMed ID: 9472204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.
    Rodríguez B; Sethi AK; Cheruvu VK; Mackay W; Bosch RJ; Kitahata M; Boswell SL; Mathews WC; Bangsberg DR; Martin J; Whalen CC; Sieg S; Yadavalli S; Deeks SG; Lederman MM
    JAMA; 2006 Sep; 296(12):1498-506. PubMed ID: 17003398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients.
    Valentine ME; Jackson CR; Vavro C; Wilfert CM; McClernon D; St Clair M; Katz SL; McKinney RE
    Pediatr Infect Dis J; 1998 Jan; 17(1):18-23. PubMed ID: 9469389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
    Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
    JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
    Kim S; Hughes MD; Hammer SM; Jackson JB; DeGruttola V; Katzenstein DA
    AIDS Res Hum Retroviruses; 2000 May; 16(7):645-53. PubMed ID: 10791875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.